Abstract
Objective: There is evidence to suggest a beneficial role for growth factors, including vascular endothelial growth factor (VEGF), in tissue repair and proliferation after injury within the lung. Whether this effect is mediated predominantly by actions on endothelial cells or epithelial cells is unknown. This study tested the hypothesis that VEGF acts as an autocrine trophic factor for human adult alveolar epithelial cells and that under situations of pro-apoptotic stress, VEGF reduces cell death.
Design: In vitro cell culture study looking at the effects of 0.03% H2O2 on both A549 and primary distal lung epithelial cells.
Measurement and Main Results: Primary adult human distal lung epithelial cells express both the soluble and membrane-associated VEGF isoforms and VEGF receptors 1 and 2. At physiologically relevant doses, soluble VEGF isoforms stimulate wound repair and have a proliferative action. Specific receptor ligands confirmed that this effect was mediated by VEGF receptor 1. In addition to proliferation, we demonstrate that VEGF reduces A549 and distal lung epithelial cell apoptosis when administered after 0.03% H2O2 injury. This effect occurs due to reduced caspase-3 activation and is phosphatidylinositol 3'-kinase dependent.
Conclusion: In addition to its known effects on endothelial cells, VEGF acts as a growth and anti-apoptotic factor on alveolar epithelial cells. VEGF treatment may have potential as a rescue therapy for diseases associated with alveolar epithelial damage such as acute respiratory distress syndrome.
Original language | English |
---|---|
Pages (from-to) | 2164-2170 |
Number of pages | 7 |
Journal | Critical Care Medicine |
Volume | 35 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sept 2007 |
Keywords
- vascular endothelial growth factor
- apoptosis
- acute respiratory distress syndrome
- epithelium repair
- IN-VITRO
- PULMONARY-EDEMA
- INJURY
- PROLIFERATION
- PATHWAY
- ACTIVATION
- FAS
- OVEREXPRESSION
- EMPHYSEMA
- PROTECTS